Önder Arslan
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Hematology 51
- Hematopoietic Stem Cell Transplantation 37
- Acute Myeloid Leukemia Research 9
- Blood groups and transfusion 6
- Platelet Disorders and Treatments 6
- Genetics 17
- Chronic Lymphocytic Leukemia Research 7
- Mesenchymal stem cell research 7
- Co-authors
- Mutlu Arat (34 shared papers)Osman İlhan (50 shared papers)Günhan Gürman (46 shared papers)Muhıt Özcan (51 shared papers)Hamdi Akan (30 shared papers)Nahıde Konuk (22 shared papers)Meral Beksaç (21 shared papers)A. Oruc Uysal (14 shared papers)
- Journals
- Bone Marrow Transplantation (8 papers)Transplantation and Cellular Therapy (7 papers)Blood (6 papers)Clinical Transplantation (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- TürkiyeUnited StatesIran
In The Last Decade
Önder Arslan
76 papers receiving 2.5k citations
Önder Arslan's Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 845
- Oncology 1.1k
- Public Health, Environmental and Occupational Health 818
- Genetics 236
- Immunology 431
Countries citing papers authored by Önder Arslan
This map shows the geographic impact of Önder Arslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Önder Arslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Önder Arslan more than expected).
Fields of papers citing papers by Önder Arslan
This network shows the impact of papers produced by Önder Arslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Önder Arslan. The network helps show where Önder Arslan may publish in the future.
Co-authors
The 25 scholars most cited alongside Önder Arslan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Hit paper breakdown → | 2017 | 1693 |
| 2 | 2004 | 79 | |
| 3 | 2002 | 59 | |
| 4 | 2007 | 56 | |
| 5 | 2011 | 55 | |
| 6 | 1997 | 46 | |
| 7 | 2007 | 39 | |
| 8 | 1999 | 33 | |
| 9 | 2024 | 28 | |
| 10 | 2004 | 25 | |
| 11 | 2002 | 23 | |
| 12 | 2003 | 22 | |
| 13 | Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. | 1998 | 21 |
| 14 | 2001 | 20 | |
| 15 | 2004 | 19 | |
| 16 | 2007 | 19 | |
| 17 | 2009 | 18 | |
| 18 | 2010 | 18 | |
| 19 | 1998 | 17 | |
| 20 | 2016 | 16 |
About Önder Arslan
Önder Arslan is a scholar working on Hematology, Genetics, Oncology, Immunology and Pathology and Forensic Medicine, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (37 papers), Acute Myeloid Leukemia Research (9 papers), Polyomavirus and related diseases (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Mesenchymal stem cell research (7 papers), Blood groups and transfusion (6 papers), Platelet Disorders and Treatments (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Hematology (845 citations), Oncology (1.1k citations), Public Health, Environmental and Occupational Health (818 citations), Genetics (236 citations) and Immunology (431 citations). Önder Arslan has collaborated with scholars based in Türkiye, United States and Iran. Frequent co-authors include Mutlu Arat, Osman İlhan, Günhan Gürman, Muhıt Özcan, Hamdi Akan, Nahıde Konuk, Meral Beksaç, A. Oruc Uysal, Klara Dalva and Taner Demirer. Their work appears in journals such as Bone Marrow Transplantation, Transplantation and Cellular Therapy, Blood, Clinical Transplantation and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.